top of page

Viromarkers at EASL 2025!

  • Writer: Sara Gerbasio
    Sara Gerbasio
  • May 12
  • 1 min read

Updated: 7 days ago


Viromarkers presented its first poster!


Lorenzo Piermatteo from the University of Rome Tor Vergata presented “In HDV sub-genotypes 1, the high degree of genetic variability can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity” at EASL 2025.


The rest of our consortium was also highly involved in the conference, with Roboscreen, ELPA, and the University of Rome Tor Vergata attending and presenting.




This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement
No 101194735. The JU receives support from the European Union’s Horizon Europe research and innovation
programme and COCIR, EFPIA, Europa Bío, MedTech Europe, and Vaccines Europe and Roboscreen.

All IHI partner logos_1 line.png
  • Instagram
  • LinkedIn
bottom of page